Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II study — Meletios A Dimopoulos (2004) | RDL Network
Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II study
Arun Azad, Nattakorn Dhiantravan, Louise Emmett, Anthony M. Joshua, Ian Vela, David A. Pattison, Roslyn J. Francis, Scott Williams, Shahneen Sandhu, Ian D. Davis, Nitika Neha, Mathias Bressel, Declan G. Murphy, Michael S. Hofman
Ivan Špıčka, Enrique M. Ocio, Heather Oakervee, Richard Greil, Raymond H. Banh, Shang‐Yi Huang, James M. D’Rozario, Meletios A Dimopoulos, Sara Martínez, Sonia Extremera, Carmen Kahatt, Vicente Alfaro, Angelo Michele Carella, Nathalie Meuleman, Roman Hájek, Argiris Symeonidis, Chang‐Ki Min, Paul Cannell, Heinz Ludwig, Pieter Sonneveld, María‐Victoria Mateos
Discussion(0)
No comments yet. Be the first to comment.